Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/22393Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kostapanos, M. S. | en |
| dc.contributor.author | Liberopoulos, E. N. | en |
| dc.contributor.author | Goudevenos, J. A. | en |
| dc.contributor.author | Mikhailidis, D. P. | en |
| dc.contributor.author | Elisaf, M. S. | en |
| dc.date.accessioned | 2015-11-24T19:23:58Z | - |
| dc.date.available | 2015-11-24T19:23:58Z | - |
| dc.identifier.issn | 0008-6363 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/22393 | - |
| dc.rights | Default Licence | - |
| dc.subject | Anti-Arrhythmia Agents/*therapeutic use | en |
| dc.subject | Atrial Fibrillation/*drug therapy | en |
| dc.subject | Death, Sudden, Cardiac/prevention & control | en |
| dc.subject | Humans | en |
| dc.subject | Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use | en |
| dc.title | Do statins have an antiarrhythmic activity? | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | 10.1016/j.cardiores.2007.02.029 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/17383620 | - |
| heal.identifier.secondary | http://cardiovascres.oxfordjournals.org/content/75/1/10.full.pdf | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2007 | - |
| heal.abstract | Sudden cardiac death, which is mainly associated with the presence of life-threatening ventricular arrhythmias, is a common 'killer' among patients with coronary artery disease. Moreover, atrial fibrillation is the most common arrhythmia encountered in the clinical practice. The beneficial effect of statins on cardiovascular morbidity and mortality is well-established, while the exact role of this class of drugs against arrhythmias remains unclear. This review discusses the effect of statin treatment on arrhythmias that are commonly seen in the clinical setting. The underlying pathophysiological mechanisms are also overviewed. Compelling evidence from the majority of the studies reviewed shows that statins exhibit a protective effect against the occurrence of ventricular arrhythmias and atrial fibrillation. | en |
| heal.journalName | Cardiovasc Res | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Kostapanos-2007-Do statins have an a.pdf | 290.42 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
